Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma.
| Image |  |
|---|---|
| Description | scientific article published on 5 October 2017 |
| Author/s |
author: Mohammed Milhem Axel Hauschild Claus Garbe |
| Publication date | October 5, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |